Kite Pharma (Nasdaq: KITE) announced the publication of clinical results in a cohort of patients demonstrating the potential to treat ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE